BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24040012)

  • 1. Suramin: a potential therapy for diabetic nephropathy.
    Korrapati MC; Howell LA; Shaner BE; Megyesi JK; Siskind LJ; Schnellmann RG
    PLoS One; 2013; 8(9):e73655. PubMed ID: 24040012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-induced renal injury in rats is attenuated by suramin.
    Korrapati MC; Shaner BE; Neely BA; Alge JL; Arthur JM; Schnellmann RG
    J Pharmacol Exp Ther; 2012 Oct; 343(1):34-43. PubMed ID: 22736507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.
    Li L; Emmett N; Mann D; Zhao X
    Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice.
    Chung JY; Tang PM; Chan MK; Wang L; Huang XR; To KF; Ma RC; Lan HY
    Int J Biol Sci; 2022; 18(14):5489-5502. PubMed ID: 36147472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
    Xu BH; Sheng J; You YK; Huang XR; Ma RCW; Wang Q; Lan HY
    Metabolism; 2020 Feb; 103():154013. PubMed ID: 31734275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.
    Wu JS; Shi R; Lu X; Ma YM; Cheng NN
    PLoS One; 2015; 10(3):e0122661. PubMed ID: 25803610
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yoon JJ; Park JH; Kim HJ; Jin HG; Kim HY; Ahn YM; Kim YC; Lee HS; Lee YJ; Kang DG
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30841605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad3 Pathways in db/db Diabetic Mice.
    Fan Z; Qi X; Yang W; Xia L; Wu Y
    Arch Med Res; 2020 Aug; 51(6):524-534. PubMed ID: 32473749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB Inhibitor Parthenolide Promotes Renal Tubules Albumin Uptake in Type 2 Diabetic Nephropathy.
    Hao QF; Wang BB; Zhang W; Qiu W; Liu QL; Li XM
    Chin Med Sci J; 2020 Mar; 35(1):31-42. PubMed ID: 32299536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
    Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling.
    He H; Wang H; Chen X; Zhong Y; Huang XR; Ma RC; Wang C; Lan HY
    Int J Biol Sci; 2024; 20(1):200-217. PubMed ID: 38164169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of oryeongsan against renal inflammation and glomerulosclerosis in db/db mice.
    Yoon JJ; Lee YJ; Kang DG; Lee HS
    Am J Chin Med; 2014; 42(6):1431-52. PubMed ID: 25482677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ethyl Acetate Extract of
    Lin CH; Shih CC
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
    Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
    Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
    Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
    Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
    Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
    Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.